Little is known of the ability of hypoglycaemic infants who are small for gestational age (SGA) to mount the coordinated hormonal and metabolic counterregulatory response that is seen in healthy older subjects during glycopenia. This response was studied in 22 SGA infants (birth weight <10th centile) by measuring the blood concentrations of glucose, intermediary metabolites, and glucoregulatory hormones.
Hypoglycaemia results in a reduced availability of glucose supply for vital organ function and may lead to neuroglycopenia. Healthy, mature subjects respond to this by increasing hepatic glucose production and generating alternative fuels, principally nonesterified fatty acids and, by ,B oxidation, ketone bodies. This response is under hormonal control, with suppression of insulin secretion and increased secretion of the counterregulatory hormones, such as glucagon, cortisol, and catecholamines. -.
Small for gestational age (SGA) infants are known to be at risk for hypoglycaemia, and it has been suggested that the counterregulatory response to hypoglycaemia is deficient. 4 The respective metabolic responses to hypoglycaemia in appropriate weight for gestational age (AGA) and SGA infants have been compared5 6 and it has been shown that AGA infants, like adults, mount a ketogenic response, but that this is deficient in many SGA infants. It is not known whether this is, in turn, the result of a deficient hormonal counterregulatory response. To date, the simultaneous measurement of glucoregulatory hormones, in the context of the metabolic response to low blood glucose concentrations, has not been reported in a homogenous group of babies. The present study examined the profiles of metabolic fuels and counterregulatory hormones in SGA infants, in order to identify possible deficiencies in the hormonal and metabolic response to hypoglycaemia.
Subject and methods
The subjects were 22 SGA neonates (birth weight <10th centile) of mixed gestation, cared for in two neonatal units, who were thought to be hypoglycaemic on the day of study (blood glucose concentration <2-6 mmol/I on at least two occasions), and for whom a clinical decision had been made to treat with intravenous glucose infusion. Blood glucose monitoring was by BM stick measurement (BM Diagnostics) on one neonatal unit (12 babies), and by immediate laboratory measurement, using a Yellow Springs analyser, on the other unit (10 babies). No infant had a coexisting clinical complication.
Blood samples were collected from each baby before treatment with intravenous glucose or before the increase in glucose infusion rate if the baby was already receiving intravenous glucose. For ethical reasons, treatment was not delayed by the baby's inclusion in the study. A sample of 1-5 ml free flowing blood was taken for subsequent measurement of blood concentrations of glucose and intermediary metabolites and plasma glucoregulatory hormone. Blood for plasma glucagon assay was collected into a tube containing aprotinin. Sample tubes were stored on ice during collection, and plasma for hormone assay was immediately separated and stored at -80°C.
Concentrations of blood glucose, lactate, pyruvate, alanine, glycerol, ketone bodies, and plasma non-esterified fatty acids were assayed as described previously.5 Plasma insulin, cortisol, and glucagon concentrations were determined by radioimmunoassay,7-9 and a radioenzymatic method was used for the assay of plasma adrenaline and noradrenaline.1I Data were analysed using the SPSS-X package. Blood concentrations of lactate, pyruvate, alanine, and glycerol were summed to give total gluconeogenic substrate concentration. For this cohort of infants the concentrations of metabolites and hormones were found not to have a normal distribution, and some infants had circulating ketone body, glucose, and insulin concentrations that were at the lower level of assay sensitivity. Therefore, non-parametric tests were used, with Spearman rank correlation to assess relationships between variables.
For each infant, the mid-arm circumference:head circumference ratio (MAC:HC) was calculated as a measure of the degree of asymmetry of growth retardation." Birthweight and MAC:HC SD scores were calculated, that is the number of SDs these measures lay from the 50th centile.
Ethical approval for the study was granted by the ethics committee of Newcastle Health Authority, and parents gave informed consent for inclusion of their baby in the study. and the time since the last feed. 
Results
Details of the infants are given in the table. All infants were at least 9 hours old and all had received enteral milk feeds; samples were taken at least one hour after the last enteral feed. Eight infants were receiving intravenous glucose at the time samples were taken. None of the infants had clinical symptoms associated with hypoglycaemia, and they had no other systemic disorder. Four babies had true blood glucose concentrations >3 0 mmol/l at the time of commencement of the study. For all four of these babies, diagnosis of hypoglycaemia was originally made by BM stick estimation of blood glucose concentrations. Eight babies had true blood glucose concentrations 2-6-3-0 mmol/l, and 10 babies had true blood glucose <2-6 mmoll when the study commenced. Figure 1 demonstrates the interrelationships between fuel concentrations. There were no significant relationships between blood glucose and total gluconeogenic substrate concentrations. Plasma non-esterified fatty acid and blood ketone body concentrations were low. The negative relationships between blood glucose concentrations and the respective ketone body and non-esterified fatty acid concentrations, seen in AGA infants,5 were absent. There was no significant relationship between fatty acid and ketone body concentrations for the babies of the present study. (fig 2) . This suggests that hyperinsulinism, persisting after the immediate postnatal period, may have contributed to hypoglycaemia.
The subjects of the present study had raised glucagon concentrations, which were similar to those found in hypoglycaemic adults. 1-3 Animal studies have demonstrated that low insulin:glucagon ratios are essential for induction of phosphoenolpyruvate carboxykinase, the major gluconeogenic enzyme, with a reduction of activity of 60% if the ratio is greater than 2.20 In addition, adult human studies have demonstrated that the ratio is reduced to less than 2 in the fasted state.21
All of the infants in the present study had ratios below this level. If circulating plasma hormone concentrations reflect the rate of pancreatic secretion, this would imply that the effects of high circulating insulin concentrations should have been balanced by glucagon activity. The presence of hypoglycaemia in the context of appropriately raised glucagon concentrations suggests that the peripheral response to glucagon was impaired. This study was not able to investigate the relationship between circulating hormone concentrations and pancreatic secretory activity nor the role of hormone receptor activity in the failure of metabolic adaptation.
Insulin is the major hormone controlling lipolysis, and glucagon promotes ketogenesis by the liver.22 Therefore, high insulin concentrations will inhibit lipolysis, regardless of glucagon concentrations, and thus reduce the availability of substrate for ketogenesis. It is possible that this was the mechanism for hypoketonaemia in the present study, but ketone body turnover studies would be required to confirm this.
There is evidence from animal studies that neonates do not have a fully functional sympathoadrenal response to hypoglycaemia, and it has been suggested that this is secondary to an immaturity of neural pathways. 23 24 This was not supported by a study of human neonates, which demonstrated a marked noradrenergic response to hypoglycaemia. 25 However, in this latter study, hypoglycaemia was induced by abruptly discontinuing high rate glucose infusion and the only SGA infant studied had systemic complications, so the findings may not be applicable to spontaneously occurring hypoglycaemia in otherwise well SGA infants. Increased urinary excretion of catecholamines has been demonstrated for SGA infants during hypoglycaemia but, unfortunately, this particular study did not record plasma catecholamine concentrations. 26 Adrenaline concentrations varied little among the infants in the present study, were similar to those found in moderately hypoglycaemic adults (blood glucose >2 0 mmolll), but were lower than those found in severely hypoglycaemic adults (blood glucose <2-0 mmol/1).2 3 On the other hand, there was a wide variation in plasma concentrations of noradrenaline, and concentrations were higher than those recorded for even severely hypoglycaemic adults. However, there was no relationship between blood glucose and plasma catecholamine concentration, which suggests that the catecholamine response was not to hypoglycaemia alone, but may have represented a general stress response in this group of infants. For example, in the present study, the clinical and ethical requirement to treat hypoglycaemia without delay precluded repeated sampling from each baby under stable conditions before correction of hypoglycaemia.
The subjects of the present study were chosen because there was clinical concern regarding blood glucose homoeostasis, this concern was justified by our findings. While the aim of this study was not to investigate the reliability of BM stick measurements for the diagnosis of hypoglycaeinia, note should be made that, of 12 babies diagnosed as hypoglycaemic by BM stick measurement, four were subsequently found to have blood glucose concentrations well within the nornal neonatal range.5 This demonstrates the importance of accurate and reliable diagnostic methods for blood glucose monitoring in the neonatal period.
Though not all SGA infants experience metabolic difficulties, those who are unable to mount an adequate counterregulatory response to hypoglycaemia are unlikely to spontaneously revert to normoglycaemia or to provide, for themselves, alternative fuels. Therefore, this latter group of infants should be identified by accurate blood glucose monitoring, and an adequate exogenous supply of enteral and parental energy must be ensured. 
